170 related articles for article (PubMed ID: 1649576)
61. Synthesis and anti-HIV-1 activity of 2'-"up"-fluoro analogues of active anti-AIDS nucleosides 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC).
Watanabe KA; Harada K; Zeidler J; Matulic-Adamic J; Takahashi K; Ren WY; Cheng LC; Fox JJ; Chou TC; Zhu QY
J Med Chem; 1990 Aug; 33(8):2145-50. PubMed ID: 1695683
[TBL] [Abstract][Full Text] [Related]
62. The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus type 1.
Borkow G; Arion D; Wainberg MA; Parniak MA
Antimicrob Agents Chemother; 1999 Feb; 43(2):259-63. PubMed ID: 9925515
[TBL] [Abstract][Full Text] [Related]
63. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.
Perno CF; Yarchoan R; Cooney DA; Hartman NR; Webb DS; Hao Z; Mitsuya H; Johns DG; Broder S
J Exp Med; 1989 Mar; 169(3):933-51. PubMed ID: 2538549
[TBL] [Abstract][Full Text] [Related]
64. Synthesis of a photoaffinity analog of 3'-azidothymidine, 5-azido-3'-azido-2',3'-dideoxyuridine. Interactions with herpesvirus thymidine kinase and cellular enzymes.
Mao F; Rechtin TM; Jones R; Cantu AA; Anderson LS; Radominska A; Moyer MP; Drake RR
J Biol Chem; 1995 Jun; 270(23):13660-4. PubMed ID: 7775417
[TBL] [Abstract][Full Text] [Related]
65. Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro.
Ito M; Baba M; Mori S; Hirabayashi K; Sato A; Shigeta S; De Clercq E
Biochem Biophys Res Commun; 1990 Feb; 166(3):1095-101. PubMed ID: 1689569
[TBL] [Abstract][Full Text] [Related]
66. Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (--)-2',3'-dideoxy-3'-thiacytidine.
Kavlick MF; Shirasaka T; Kojima E; Pluda JM; Hui F; Yarchoan R; Mitsuya H
Antiviral Res; 1995 Oct; 28(2):133-46. PubMed ID: 8585767
[TBL] [Abstract][Full Text] [Related]
67. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
Gu Z; Gao Q; Fang H; Salomon H; Parniak MA; Goldberg E; Cameron J; Wainberg MA
Antimicrob Agents Chemother; 1994 Feb; 38(2):275-81. PubMed ID: 7514855
[TBL] [Abstract][Full Text] [Related]
68. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients.
Farraye FA; Mamish DM; Zeldis JB
J Med Virol; 1989 Dec; 29(4):266-7. PubMed ID: 2621453
[TBL] [Abstract][Full Text] [Related]
69. In vitro study of resistance-associated genotypic mutations to nucleoside analogs.
Gashnikova N; Plyasunova O; Kiseleva Y; Fedyuk N; Pokrovsky A
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):991-4. PubMed ID: 14565328
[TBL] [Abstract][Full Text] [Related]
70. Lamivudine (3TC) approved for combination use with AZT.
James JS
AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
[TBL] [Abstract][Full Text] [Related]
71. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains.
Mayers DL; Mikovits JA; Joshi B; Hewlett IK; Estrada JS; Wolfe AD; Garcia GE; Doctor BP; Burke DS; Gordon RK
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):215-9. PubMed ID: 7816820
[TBL] [Abstract][Full Text] [Related]
72. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants.
Kim EY; Vrang L; Oberg B; Merigan TC
AIDS Res Hum Retroviruses; 2001 Mar; 17(5):401-7. PubMed ID: 11282008
[TBL] [Abstract][Full Text] [Related]
73. Synthesis and biological evaluation of dinucleoside methylphosphonates of 3'-azido-3'-deoxythymidine and 2', 3'-dideoxycytidine.
Puech F; Gosselin G; Balzarini J; Good SS; Rideout JL; De Clercq E; Imbach JL
Antiviral Res; 1990 Jul; 14(1):11-23. PubMed ID: 1964371
[TBL] [Abstract][Full Text] [Related]
74. Characterization of reverse transcriptase activity and susceptibility to other nucleosides of AZT-resistant variants of HIV-1. Results from the Canadian AZT Multicentre Study.
Wainberg MA; Tremblay M; Rooke R; Blain N; Soudeyns H; Parniak MA; Yao XJ; Li XG; Fanning M; Montaner JS
Ann N Y Acad Sci; 1990; 616():346-55. PubMed ID: 1706573
[No Abstract] [Full Text] [Related]
75. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
76. Synthesis, in vitro anti-HIV and anti-hepatitis B activities and pharmacokinetic properties of amphiphilic heterodinucleoside phosphates containing ddC and AZT.
Schwendener RA; Peghini PA; Ludwing PS; Schott H
Nucleosides Nucleotides; 1999; 18(4-5):949-50. PubMed ID: 10432717
[TBL] [Abstract][Full Text] [Related]
77. Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine.
Balzarini J; Pelemans H; Riess G; Roesner M; Winkler I; De Clercq E; Kleim JP
J Infect Dis; 1997 Nov; 176(5):1392-7. PubMed ID: 9359746
[TBL] [Abstract][Full Text] [Related]
78. Comparison of the antiviral activities of 3'-azido-3'-deoxythymidine (AZT) and gossylic iminolactone (GIL) against clinical isolates of HIV-1.
Royer RE; Mills RG; Young SA; Vander Jagt DL
Pharmacol Res; 1995 Jan; 31(1):49-52. PubMed ID: 7540302
[TBL] [Abstract][Full Text] [Related]
79. Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes.
Schinazi RF; Chu CK; Peck A; McMillan A; Mathis R; Cannon D; Jeong LS; Beach JW; Choi WB; Yeola S
Antimicrob Agents Chemother; 1992 Mar; 36(3):672-6. PubMed ID: 1320365
[TBL] [Abstract][Full Text] [Related]
80. In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddC.
Peghini PA; Zahner R; Kuster H; Schott H; Schwendener RA
Antivir Chem Chemother; 1998 Mar; 9(2):117-26. PubMed ID: 9875383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
